Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Synovial Sarcoma, X Breakpoint 2 (SSX2) Peptide

SSX2 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN939235
  • Target See all SSX2 products
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequence
    HRWSSQNTHN IGRFSLSTSM GAVHGTPKTI THNRDPKGGN MPGPTDCVRE
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of SSX2 antibody,
    Alternative Names: SSX2 control peptide, SSX2 antibody Blocking Peptide, Anti-SSX2 Blocking Peptide, synovial sarcoma, X breakpoint 2 Blocking Peptide, HD21 Blocking Peptide, HOM-MEL-40 Blocking Peptide, MGC119055 Blocking Peptide, MGC15364 Blocking Peptide, MGC3884 Blocking Peptide, SSX Blocking Peptide, SSX2, SSX-2, SSX 2, SSX-2 Blocking Peptide, SSX 2 Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Background
    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene.
    Molecular Weight
    25 kDa
You are here:
Support